Search Results - "Slovák, L"

Hypertriglyceridemic rats fed high fat diet as a model of metabolic syndrome by Kaprinay, B, Lipták, B, Slovák, L, Švík, K, Knezl, V, Sotníková, R, Gáspárová, Z

“…People with metabolic syndrome have higher risk of cardiovascular diseases then those without. The aim of the work was to investigate whether high fat diet…”
Get full text

Hippocampal electrophysiological responses and changes in oxidative stress marker and serum lipid profile to pharmacological and non-pharmacological treatments of high-fat-fructose diet induced metabolic syndrome by Micháliková, D., Kaprinay, B. Tyukos, Sasváriová, M., Švík, K., Slovák, L., Sotníková, R., Stankovičová, T., Gáspárová, Z.

“…The aim of our study was to evaluate the possibility of influencing the risk factors of metabolic syndrome (MetS) and metabolic cognitive syndrome. As a model…”
Get full text

Effect of high-fat-fructose diet on synaptic plasticity in hippocampus and lipid profile of blood serum of rat: pharmacological possibilities of affecting risk factors by Micháliková, D., Kaprinay, B. Tyukos, Lipták, B., Švík, K., Slovák, L., Sotníková, R., Bezek, Š., Gáspárová, Z.

“…The aim of this study was to determine pharmacological possibilities of influencing the risk factors of metabolic syndrome (MetS). Hypertriacylglycerolemic…”
Get full text

Evaluation of the effect of carnosine, its novel derivative trolox-carnosine and trolox in a pre-clinical study focussing on the regulation of immunity by Slovák, L., Poništ, S., Kuncírová, V., Mihalová, D., Fedorova, T., Bauerová, K.

“…The neuroprotective or neurotoxic effects of the products of the kynurenine pathway of tryptophan metabolism highly depend on the action of…”
Get full text

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge by SCHANZ, Julie, TÜCHLER, Heinz, STEIDL, Christian, FONATSCH, Christa, PFEILSTÖCKER, Michael, NÖSSLINGER, Thomas, VALENT, Peter, GIAGOUNIDIS, Aristoteles, AUL, Carlo, LÜBBERT, Michael, STAUDER, Reinhard, KRIEGER, Otto, SOLE, Francesc, GARCIA-MANERO, Guillermo, FADERL, Stefan, PIERCE, Sherry, LE BEAU, Michelle M, BENNETT, John M, GREENBERG, Peter, GERMING, Ulrich, HAASE, Detlef, MALLO, Mar, LUNO, Elisa, CERVERA, José, GRANADA, Isabel, HILDEBRANDT, Barbara, SLOVAK, Marilyn L, OHYASHIKI, Kazuma

“…The karyotype is a strong independent prognostic factor in myelodysplastic syndromes (MDS). Since the implementation of the International Prognostic Scoring…”
Get full text

Age and acute myeloid leukemia by Appelbaum, Frederick R., Gundacker, Holly, Head, David R., Slovak, Marilyn L., Willman, Cheryl L., Godwin, John E., Anderson, Jeanne E., Petersdorf, Stephen H.

“…We conducted a retrospective analysis of 968 adults with acute myeloid leukemia (AML) on 5 recent Southwest Oncology Group trials to understand how the nature…”
Get full text

Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis by Gardi, C., Bauerova, K., Stringa, B., Kuncirova, V., Slovak, L., Ponist, S., Drafi, F., Bezakova, L., Tedesco, I., Acquaviva, A., Bilotto, S., Russo, G.L.

“…Novel therapies for rheumatoid arthritis also include the use of naturally occurring compounds possessing antioxidant properties. In the present work, the…”
Get full text

Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study by Pullarkat, Vinod, Slovak, Marilyn L., Kopecky, Kenneth J., Forman, Stephen J., Appelbaum, Frederick R.

“…We examined the prognostic impact of cytogenetics on the outcome of 200 acute lymphoblastic leukemia (ALL) patients 15 to 65 years of age enrolled in Southwest…”
Get full text

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study by Slovak, Marilyn L., Kopecky, Kenneth J., Cassileth, Peter A., Harrington, David H., Theil, Karl S., Mohamed, Anwar, Paietta, Elizabeth, Willman, Cheryl L., Head, David R., Rowe, Jacob M., Forman, Stephen J., Appelbaum, Frederick R.

“…The associations of cytogenetics with complete remission (CR) rates, overall survival (OS), and outcomes after CR were studied in 609 previously untreated AML…”
Get full text

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment by Bhatia, Ravi, Holtz, Melissa, Niu, Ning, Gray, Rachel, Snyder, David S., Sawyers, Charles L., Arber, Daniel A., Slovak, Marilyn L., Forman, Stephen J.

“…The BCR/ABL tyrosine kinase inhibitor imatinib mesylate (Gleevec, STI571; Novartis, Basel, Switzerland) has shown remarkable efficacy in the treatment of…”
Get full text

Study of anti-inflammatory activity of Fatsiphloginum™ (Fatsia japonica) and a new purified triterpene-rich extract of saponins (PS-551) in experimental model of arthritis by Tsiklauri, L, Drafi, F, Poništ, S, Slovák, L, Chrastina, M, Švík, K, Kemoklidze, Z, Kemertelidze, E, Bauerová, K

“…In this study, two extracts from Fatsia japonica-Fatsiphloginum™ (extract of triterpene glycosides containing 45-50 % of fatsiosides (FS)) and purified…”
Get full text

Revised International Prognostic Scoring System for Myelodysplastic Syndromes by Greenberg, Peter L., Tuechler, Heinz, Schanz, Julie, Sanz, Guillermo, Garcia-Manero, Guillermo, Solé, Francesc, Bennett, John M., Bowen, David, Fenaux, Pierre, Dreyfus, Francois, Kantarjian, Hagop, Kuendgen, Andrea, Levis, Alessandro, Malcovati, Luca, Cazzola, Mario, Cermak, Jaroslav, Fonatsch, Christa, Le Beau, Michelle M., Slovak, Marilyn L., Krieger, Otto, Luebbert, Michael, Maciejewski, Jaroslaw, Magalhaes, Silvia M.M., Miyazaki, Yasushi, Pfeilstöcker, Michael, Sekeres, Mikkael, Sperr, Wolfgang R., Stauder, Reinhard, Tauro, Sudhir, Valent, Peter, Vallespi, Teresa, van de Loosdrecht, Arjan A., Germing, Ulrich, Haase, Detlef

“…The International Prognostic Scoring Sytem (IPSS) is an important standard for ssessing prognosis of primary untreated adult patients with myelodysplastic…”
Get full text

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia by Stirewalt, Derek L., Kopecky, Kenneth J., Meshinchi, Soheil, Appelbaum, Frederick R., Slovak, Marilyn L., Willman, Cheryl L., Radich, Jerald P.

“…The prevalence and significance of genetic abnormalities in older patients with acute myeloid leukemia (AML) are unknown. Polymerase chain reactions and…”
Get full text

Time-dependent changes in mortality and transformation risk in MDS by Pfeilstöcker, Michael, Tuechler, Heinz, Sanz, Guillermo, Schanz, Julie, Garcia-Manero, Guillermo, Solé, Francesc, Bennett, John M., Bowen, David, Fenaux, Pierre, Dreyfus, Francois, Kantarjian, Hagop, Kuendgen, Andrea, Malcovati, Luca, Cazzola, Mario, Cermak, Jaroslav, Fonatsch, Christa, Le Beau, Michelle M., Slovak, Marilyn L., Levis, Alessandro, Luebbert, Michael, Maciejewski, Jaroslaw, Machherndl-Spandl, Sigrid, Magalhaes, Silvia M.M., Miyazaki, Yasushi, Sekeres, Mikkael A., Sperr, Wolfgang R., Stauder, Reinhard, Tauro, Sudhir, Valent, Peter, Vallespi, Teresa, van de Loosdrecht, Arjan A., Germing, Ulrich, Haase, Detlef, Greenberg, Peter L.

“…In myelodysplastic syndromes (MDSs), the evolution of risk for disease progression or death has not been systematically investigated despite being crucial for…”
Get full text

Molecular Karyotypes of Hodgkin and Reed―Sternberg Cells at Disease Onset Reveal Distinct Copy Number Alterations in Chemosensitive versus Refractory Hodgkin Lymphoma by SLOVAK, Marilyn L, BEDELL, Victoria, HSU, Ya-Hsuan, ESTRINE, Dolores B, NOWAK, Norma J, DELIOUKINA, Maria L, WEISS, Lawrence M, SMITH, David D, FORMAN, Stephen J

“…To determine the recurring DNA copy number alterations (CNA) in classical Hodgkin lymphoma (HL) by microarray-based comparative genomic hybridization (aCGH)…”
Get full text

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study by List, Alan F., Kopecky, Kenneth J., Willman, Cheryl L., Head, David R., Persons, Diane L., Slovak, Marilyn L., Dorr, Robert, Karanes, Chatchada, Hynes, Harry E., Doroshow, James H., Shurafa, Muhammad, Appelbaum, Frederick R.

“…Cyclosporine A (CsA) inhibits P-glycoprotein (Pgp)–mediated cellular export of anthracyclines at clinically achievable concentrations. This randomized…”
Get full text

Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation by Quéré, Ronan, Karlsson, Göran, Hertwig, Falk, Rissler, Marianne, Lindqvist, Beata, Fioretos, Thoas, Vandenberghe, Peter, Slovak, Marilyn L., Cammenga, Jörg, Karlsson, Stefan

“…We studied leukemic stem cells (LSCs) in a Smad4−/− mouse model of acute myelogenous leukemia (AML) induced either by the HOXA9 gene or by the fusion oncogene…”
Get full text

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study by Leith, Catherine P., Kopecky, Kenneth J., Chen, I-Ming, Eijdems, Lisette, Slovak, Marilyn L., McConnell, Thomas S., Head, David R., Weick, James, Grever, Michael R., Appelbaum, Frederick R., Willman, Cheryl L.

“…Therapeutic resistance is a major obstacle in the treatment of acute myeloid leukemia (AML). Such resistance has been associated with rapid drug efflux…”
Get full text

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors by Krishnan, Amrita, Bhatia, Smita, Slovak, Marilyn L., Arber, Daniel A., Niland, Joyce C., Nademanee, Auayporn, Fung, Henry, Bhatia, Ravi, Kashyap, Ashwin, Molina, Arturo, O'Donnell, Margaret R., Parker, Pablo A., Sniecinski, Irena, Snyder, David S., Spielberger, Ricardo, Stein, Anthony, Forman, Stephen J.

“…We analyzed data on 612 patients who had undergone high-dose chemoradiotherapy (HDT) with autologous stem cell rescue for Hodgkin's disease (HD) and…”
Get full text

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia by Stirewalt, Derek L., Kopecky, Kenneth J., Meshinchi, Soheil, Engel, Julia H., Pogosova-Agadjanyan, Era L., Linsley, Jeremy, Slovak, Marilyn L., Willman, Cheryl L., Radich, Jerald P.

“…FLT3 internal tandem duplications (FLT3/ITDs) in the juxtamembrane domain are found in approximately 25% of acute myeloid leukemia (AML) patients, ranging in…”
Get full text